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Abstract
This study was designed to evaluate the effects of long-term treatment with a-naphthyl-isothiocyanate (ANIT) on
liver histology and at the mitochondrial bioenergetic level. Since, ANIT has been used as a cholestatic agent and it has
been pointed out that an impairment of mitochondrial function is a cause of hepatocyte dysfunction leading to
cholestatic liver injury, serum markers of liver injury were measured and liver sections were analyzed in ANIT-treated
rats (i.p. 80 mg/kg/week/16 weeks). Mitochondrial parameters such as transmembrane potential, respiration, calcium
capacity, alterations in permeability transition susceptibility and ATPase activity were monitored. Histologically, the
most important features were the marked ductular proliferation, proliferation of mast cells and the presence of iron
deposits in ANIT-treated liver. Mitochondria isolated from ANIT-treated rats showed no alterations in state 4
respiration, respiratory control ratio and ADP/O ratio, while state 3 respiration was significantly decreased. No changes
were observed on transmembrane potential, but the repolarization rate was decreased in treated rats. Consistently with
these data, there was a significant decrease in the ATPase activity of treated mitochondria. Associated with these
parameters, mitochondria from treated animals exhibited increased susceptibility to mitochondrial permeability
transition pore opening (lower calcium capacity). Since, human cholestatic liver disease progress slowly overtime, these
data provide further insight into the role of mitochondrial dysfunction in the process.
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1. Introduction
Bile formation is a vital function of the liver and
its impairment is central in the pathogenesis of
cholestasis. In clinical settings, retention of hydro-
phobic bile acids within the liver is the major
pathophysiologic mechanism during cholestasis
and liver failure (Greim et al., 1972; Fischer et
al., 1996). The mechanisms resulting in cell dys-
function in animal models and human liver disease
remain obscure. Understanding the mechanisms
underlying bile acids toxicity will provide new
therapeutic strategies to intervene in the clinical
management of cholestatic disease. Cholestasis
was mimicked by a-naphthyl-isothiocyanate
(ANIT) administration to rats, a well character-
ized cholestatic agent (Plaa and Priestley, 1976).
Liver injury caused by ANIT is the ultimate
consequence of increased permeability of the tight
junctions between hepatocytes and bile duct
epithelial cells, and the subsequent diffusion of
osmotically active solutes from the bile into
plasma.
Mitochondria are essential for cellular energy
metabolism and calcium homeostasis. It is there-
fore not surprising that mitochondrial dysfunction
can cause cell death through ATP depletion and
calcium dysregulation, playing a central role in the
initiation of both apoptotic and necrotic cell death
(Petit et al., 1995; Wallace and Starkov, 2000). A
major player in this process is the mitochondrial
permeability transition (MPT), widely implicated
in the pathophysiology of cell death caused by a
number of agents (Lemasters et al., 1998). It is
characterized by an increase in non-specific perme-
ability of the inner membrane to low-molecular-
weight solutes leading to mitochondrial membrane
depolarization, mitochondrial calcium release, mi-
tochondrial swelling and inhibition of oxidative
phosphorylation (Zoratti and Szabo, 1995), and
specifically inhibited by CyA (Broekemeier et al.,
1989).
In recent studies, we were able to show that rats
with chronic cholestasis have impaired mitochon-
drial function and this finding can be explained
entirely by the disruption of mitochondrial cal-
cium homeostasis (Rolo et al., 2002a). This
mechanism may therefore contribute to bile acids
hepatotoxicity with alteration of some important
cell functions. Additionally, it may explain the
characterization of cholestatic liver diseases by
accumulation of hepatotoxic substances, mito-
chondrial dysfunction (Schaffner et al., 1971;
Krahenbuhl et al., 1992; Gores et al., 1998; Rolo
et al., 2000) and impairment of liver antioxidant
defense (Sokol et al., 1993).
Our next questions were: (i) which mechanisms
contribute to impaired mitochondrial function in
rats with long-term cholestasis, (ii) are these
changes similar to the ones observed with the
short-term model of cholestasis, and (iii) are these
changes histologically evident. Concerning the
relevance and actuality of these questions, this
study was undertaken to clarify the persistence of
liver injury associated with mitochondrial dysfunc-
tion, in an ANIT-induced model of long-term
cholestasis.
2. Materials and methods
2.1. Materials
ANIT, which was dissolved in olive oil, and
cyclosporin A (CyA), used as ethanolic solution,
were purchased from Sigma Chemical Co. (St.
Louis, USA); Calcium Green 5-N was purchased
from Molecular Probes (Leiden, The Nether-
lands). All other reagents and chemicals used
were of the highest grade of purity commercially
available.
2.2. Induction and characterization of cholestasis
Female Wistar rats (12 weeks) from our colony
were used (Animal Research Center Laboratory,
University Hospitals, Coimbra, Portugal). The use
and care of the animals for these studies were
reviewed and approved by the Institutional Ani-
mal Care and Use Committee at the University of
Coimbra. Animals were kept under controlled
light (12 h day/night cycle), temperature (22/
24 8C) and humidity (50/60%) conditions and
with free access to powdered rodent chow (diet
URF1, Charles Rivers, France) and water (pH
5.5). Animals were divided randomly into two
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groups of eight animals each. To induce choles-
tasis, ANIT (80 mg/kg) was administrated intra-
peritoneally, and this treatment was repeated for
16 weeks. Control animals received an equivalent
volume of the vehicle. One week after the 16th
ANIT treatment, rats were anesthetized (i.m.) with
ketamin chloride (88.5 mg/kg, Park Davies, USA)
and chlorpromazine chloride (2.65 mg/kg, Lab.
Victoria, Portugal) and their weight was recorded.
A blood sample (2 ml) was collected from cardiac
puncture for measurement of serum markers of
liver injury. Analyses were performed using com-
mercial kits from Olympus, Tokyo, Japan and
from Beckman, Fullerton, CA.
2.3. Liver morphology
Livers from four untreated female Wistar rats
and from four treated female Wistar rats were
removed quickly and immediately after the sacri-
fice and fixed in 10% buffered formaline, processed
routinely, and embedded in paraffin. The 4-mm
thick sections were deparaffinized with xylene and
rehydrated through decreasing concentrations of
ethanol for staining with haematoxylin and eosin
(H&E). To identify mast cells in supporting tissues
and iron deposits, liver sections were also stained,
respectively, with toluidine blue (Caballero et al.,
1993) and Perls’ Prussian blue (Churukian, 2002).
2.4. Preparation of mitochondria
Normal and cholestatic rats were maintained ad
libitum for at least 12 h, before being sacrificed,
according to a previously established method
(Gazotti et al., 1979), with slight modifications.
Homogenization medium contained 250 mM
sucrose, 5 mM HEPES (pH 7.4), 0.2 mM EGTA,
0.1 mM EDTA and 0.1% defatted BSA (bovine
serum albumin). EDTA, EGTA and defatted BSA
were omitted from the final washing medium and
adjusted to pH 7.2. The mitochondrial pellet was
washed twice, suspended in the washing medium
and immediately used. Protein was determined by
the Biuret method, using BSA as a standard
(Gornall et al., 1949).
2.5. Membrane potential (DC) measurements
The mitochondrial transmembrane potential
was estimated by calculating transmembrane dis-
tribution of tetraphenylphosphonium ion (TPP)
with a TPP-selective electrode prepared in our
laboratory, as previously reported (Kamo et al.,
1979; Palmeira et al., 1994) using a calomel
electrode as a reference, since accumulation and
release of TPP by coupled mitochondria is
directly correlated to membrane potential (Kamo
et al., 1979). Therefore, TPP uptake was mea-
sured from the decreased TPP concentration in
the medium of the electrode. The potential differ-
ence between the selective and the reference
electrodes was measured with an electrometer
and recorded continuously. A matrix volume of
1.1 ml/mg was assumed and valinomycin was used
to calibrate the baseline. Reactions were carried
out at 25 8C in 1 ml of the reaction media (130 mM
sucrose, 50 mM KCl, 5 mM MgCl2, 5 mM
KH2PO4, 5 mM HEPES, pH 7.2), supplemented
with 3 mM TPP, 2 mM rotenone, 1 mg mitochon-
dria and 5 mM succinate. To induce state 3, 200
nmol ADP were used. Oxygen consumption was
measured simultaneously, as described below. In
order to evaluate the induction of MPT in the
presence of calcium and phosphate, membrane
potential was also evaluated. Reactions were
carried out at 25 8C, in 1 ml of reaction medium
(200 mM sucrose, 10 mM Tris/Mops (3-[N -
morpholino]propanesulfonic acid) (pH 7.4), 1
mM KH2PO4 and 10 mM EGTA), supplemented
with 2 mM rotenone, 1 mg mitochondria and 5
mM succinate. To induce MPT, pulses of calcium
were added, until the loss of DC compatible with
the opening of MPT was recorded.
2.6. Mitochondrial respiration
Oxygen consumption of isolated mitochondria
was determined polarographically at 25 8C with a
Clark oxygen electrode, connected to a suitable
recorder in a closed chamber with magnetic
stirring. Mitochondria (1 mg) and respiratory
substrate (succinate, 5 mM) and rotenone (2 mM)
were added to the standard reaction medium (1
ml). To induce state 3, 200 nmol ADP were used.
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The respiratory control ratio (RCR) and ADP/O
ratios were calculated according to Chance and
Williams (1956).
2.7. Measurement of mitochondrial permeability
transition
Mitochondrial swelling was estimated by
changes in light scattering as monitored spectro-
photometrically at 540 nm (Palmeira and Wallace,
1997). The reaction medium (200 mM sucrose, 10
mM Tris/Mops (3-[N -morpholino]propanesulfo-
nic acid) (pH 7.4), 1 mM KH2PO4 and 10 mM
EGTA), supplemented with 2 mM rotenone, 0.5
mg/ml of oligomycin and 0.6 mg mitochondria was
stirred continuously and the temperature main-
tained at 25 8C. The experiments were started by
the addition of 5 mM succinate. Calcium (50 mM
CaCl2) was added prior to all the other com-
pounds.
2.8. Measurement of mitochondrial calcium fluxes
The uptake and following release of calcium by
isolated liver mitochondria was determined using a
calcium-sensitive fluorescent dye, Calcium Green
5-N (Rajdev and Reynolds, 1993). The reactions
were carried out at 25 8C, in 2 ml of reaction
medium (200 mM sucrose, 10 mM Tris/Mops (3-
[N -morpholino]propanesulfonic acid) (pH 7.4), 1
mM KH2PO4 and 10 mM EGTA), supplemented
with 2 mM rotenone, 0.6 mg mitochondria, 0.4 mM
oligomycin and 100 nM Calcium Green 5-N, and
stirred continuously in a water-jacketed cuvette
holder. Fluorescence (excitation 505 nm; emission
531 nm) was monitored continuously for 50 s,
prior to the addition of calcium (CaCl2) to a final
concentration of 15 mM. Fluorescence was mon-
itored continuously for an additional 4 min, and
stopped with excess EGTA to obtain the basal
line. Calcium fluxes are expressed as relative
fluorescence units (RFU).
2.9. Measurement of mitochondrial ATPase
activity
ATPase activity was determined by quantifica-
tion of inorganic phosphate released in the assay
medium by the procedure of Taussky and Shorr
(1953). The reaction was carried out in 2 ml of the
respiratory medium and supplemented with 2-mM
rotenone and mitochondria (1 mg). The reaction
was initiated by the addition of 3 mM Mg/ATP.
Mitochondrial ATPase activity was determined by
the difference obtained in the presence and in the
absence of oligomycin (2 mg), a specific inhibitor of
F0F1 ATPase.
2.10. Statistical data analysis
The results are presented as mean9/S.E.M. of
the number of experiments indicated. Statistical
significance was determined by the one-way AN-
OVA Student/Newman/Keuls post-t-test for
multiple comparisons. A P value B/0.05 was
considered statistically significant.
3. Results
3.1. Characterization of animals
Previous reports have been shown that ANIT is
a cholestatic agent that produces cholestasis in a
reproducible and dose-dependent manner Gold-
farb et al., 1962; Rolo et al., 2002a). On the day of
experiment (1 week after 16 weeks of ANIT
administration), several markers of liver injury
were measured. As described in Table 1, biochem-
ical analyses showed the cholestatic potential of
ANIT, since there was an elevation in serum
markers such as conjugated bilirubin, alkaline
phosphatase, g-glutamyltransferase and alanine
aminotransferase. Citrate synthase activity and
the yield of mitochondrial preparations were also
similar among the two groups of animals (data not
shown).
3.2. Liver morphology
In all treated animals absence of hepatocellular
damage (Fig. 1A) and moderated to marked
ductular proliferation were the most important
features (Fig. 1B). In control animals, no prolif-
eration of mast cells was observed (Fig. 2A), while
in ANIT-treated rats portal tracts and some
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sinusoids (Fig. 2B) were infiltrated by large
numbers of mast cells (stain purple). Iron-deposits
(stain blue) at Kupffer cells and portal macro-
phages were also observed in all treated rats (Fig.
3B). Only one rat had some portal edema (Fig.
1C).
3.3. Liver mitochondrial respiratory indexes and
transmembrane potential
Respiratory parameters from liver mitochondria
isolated from ANIT-treated and control rats, were
evaluated using succinate as a substrate. Mito-
chondria isolated from ANIT-treated rats showed
no significant alteration in state 4 respiration,
RCR and ADP/O, compared with the rates in
mitochondria from controls (Table 2). State 3
respiration was significantly decreased in ANIT-
treated rats. Additionally, when both preparations
were energized with succinate, they developed
similar transmembrane potential (DC) while after
ADP addition, DC and the repolarization rate
were significantly decreased (Table 3 and Fig. 4).
Taken together the results in ANIT-treated rats,
namely the decrease in state 3 respiration, the
decrease in repolarization rate, as well as the
observed decrease in DC after ADP addition,
suggest an effect at the ATP-synthase level. To
verify this hypothesis, we determined ATPase
activity in both preparations (see insert in Fig.
4). There was a significant decrease in the ATPase
activity of mitochondria from ANIT-treated when
compared to control rats (85.59/19.1 in ANIT vs.
120.69/12.4 nmol Pi/mg/min in control mitochon-
Table 1
Characterization of the animals
Parameter Control One week after 16th
injection
Body weight (g) 309.79/10.9 263.19/6.8*
















Note: Data represent the mean9/S.E.M. (n/7) from control
animals (1 week after 16th injection with vehicle) and animals 1
week after 16th ANIT treatment. IU, International units.
* PB/0.05, when compared to controls.
Fig. 1. Liver tissue of untreated and treated Wistar rats: (A)
portal tract and liver cells of untreated Wistar rat (H & E
400/); (B) portal tract and liver cells of treated Wistar rat:
proliferation of bile ductules and normal hepatocellular struc-
ture (H&E 200/); (C) portal edema in one treated Wistar rat
(H&E 125/).
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dria), confirming that after 16 weeks of treatment
this key enzymatic complex is severely affected.
3.4. Calcium-induced mitochondrial permeability
transition
We evaluated the calcium concentration that
should be applied to assess the susceptibility of
both preparations to MPT induction. Calcium
capacity of liver mitochondria from ANIT-treated
and control rats was determined by monitoring the
effect of the addition of small pulses of calcium in
mitochondrial DC, measured with a TPP-selec-
tive electrode. Our results shown that mitochon-
dria from ANIT-treated rats presented a lower
capacity of accumulating calcium, since they could
carry a small number of pulses before the loss of
DC, compatible within the opening of MPT pore
(Fig. 5). This decline in DC was abolished in the
presence of CyA, a well known inhibitor of the
MPT (data not shown).
Another evidence of the lower calcium capacity
(consistent with a higher susceptibility to MPT
pore opening) of mitochondria from ANIT-trea-
ted rats, comes from determinations of extrami-
tochondrial calcium movements using the
fluorescent calcium-sensitive probe Calcium Green
5-N. Data obtained with this technique confirm
that mitochondria from control rats were able to
retain calcium longer than those from ANIT-
treated rats, indicating that mitochondria from
treated animals are more susceptible to the induc-
Fig. 2. Liver tissue of untreated and treated Wistar rats: (A)
some mast cells confined to portal tract of untreated Wistar rats
(Toluidine blue 500/); (B) portal tract of treated Wistar rats
infiltrated by large numbers of mast cells (Toluidine blue
640/).
Fig. 3. Liver tissue of untreated and treated Wistar rats: (A)
focal iron-deposits at Kupffer cells of untreated Wistar rats
(Perls’ Prussian blue 400/); (B) iron-deposits at Kupffer cells
and portal macrophages of treated Wistar rats (Perls’ Prussian
blue 250/).
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tion of MPT (Fig. 6). Cyclosporin A was able to
inhibit calcium release, thus confirming MPT
induction.
Concomitantly with these assays, we have
evaluated the effect of long-term ANIT treatment
on calcium-induced mitochondrial swelling by
measuring changes in absorption at 540 nm, of a
mitochondrial suspension. Our results shown that
the same amount of calcium (50 mM), when added
to mitochondria from ANIT-treated rats, caused a
larger amplitude decrease in absorption at 540 nm
(Fig. 7). In the presence of CyA, this decrease was
clearly prevented indicating that the observed
swelling was due to MPT pore opening.
4. Discussion
Our report for the first time describes the
persistence of coexisting mitochondrial dysfunc-
tion and ductular proliferation following long-
term ANIT administration to rats. In numerous
studies, ANIT has been employed as a mean to
investigate the developmental aspects of the chole-
static type of hepatotoxic response (Goldfarb et
al., 1962; Plaa and Priestley, 1976; Lock et al.,
1982). Independently of the initiating event of
cholestasis and the disease process, impairment of
bile formation leads to an accumulation of bile
acids within the hepatocyte, culminating in toxicity
to the cells (Greim et al., 1972). Even in cholestasis
caused by a primary insult to bile ducts, hepato-
cellular injury is an invariant feature.
To establish a condition of long-term cholesta-
sis, animals were treated with a single, weekly
injection of ANIT, based in previous studies (Rolo
et al., 2002a,b). The increase in serum markers, 1
week after the last ANIT injection, clearly shows
the onset of ANIT-induced cholestasis. The in-
creased paracellular permeability induced by
ANIT causes the regurgitation of biliary contents
into the blood, giving rise to the biochemical
Table 2
Effect of ANIT-treatment on liver mitochondria respiratory indexes
Condition State 4 (nmol O/mg/min) State 3 (nmol O/mg/min) RCR ADP/O (nmol ADP/nmol O)
Control 15.09/4.31 (n/6) 71.19/5.74 (n/6) 4.459/1.05 (n/6) 1.539/0.29 (n/6)
ANIT 14.39/3.07 (n/7) 57.39/3.9* (n/7) 3.829/0.44 (n/7) 1.569/0.24 (n/7)
Mitochondria (1 mg protein) were incubated in 1 ml of the respiratory standard medium. RCR and ADP/O were determined
accordingly to Chance and Williams (1956). Values are given as mean9/S.E.M. of the number of independent experiments indicated,
performed with at least 3 different mitochondrial preparations.
* PB/0.05, when compared to controls.
Table 3
Effect of ANIT-treatment on liver mitochondria transmembrane potential
Condition DC (-mV) DADP (-mV) DCrep (-mV) Rep. Rate (% control)
Control 215.59/5.00 (n/8) 30.49/2.58 (n/8) 213.09/4.01 (n/8) 100.09/8.83 (n/8)
ANIT 216.09/3.06 (n/7) 24.29/3.08* (n/7) 212.89/2.38 (n/7) 58.19/3.98* (n/7)
Values are given as mean9/S.E.M. of the number of independent experiments indicated, performed with at least 3 different
mitochondrial preparations. The membrane potential was measured after the addition of 5 mM succinate, as the respiratory substrate
(‘energization’) and after the addition of 200 nmol ADP (DADP). ‘Repolarization’, corresponds to the recovery of membrane
potential, after the complete phosphorylation of ADP added. Repolarization rate was determined, as the time required to the complete
phosphorylation of ADP added. Lag phase reflects the time required to phosphorylate the ADP added. In all experiments, the baseline
was determined by addition of 10 ng/ml of valinomicin at the end of experiments, in order to completely abolish membrane potential.
* PB/0.05, when compared to controls.
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changes seen. Bile acids and bilirubin are described
as elevated in serum, as well as the levels of
enzymes normally present in bile. Although, we
have not examined the levels of bile acids, in both
serum or plasma, previous studies regarding short-
term effects of ANIT on liver function, have
clearly shown that a rise in serum bilirubin levels
was associated with a reduction of bile flow
(Capizzo and Roberts, 1970; Kossor et al., 1993),
giving rise to bile acids accumulation. Interest-
ingly, in a previous study regarding short-term
chronic ANIT administration (Rolo et al., 2002b),
we have observed that, 1-week after the sixth
ANIT treatment, biochemical parameters returned
to control levels. So, the evidence of serum
markers of liver injury observed after this long
treatment is the consequence of hepatocellular
injury. Goldfarb et al. (1962) observed, in early
stages, ANIT-induced small bile ducts epithelial
necrosis which results in cessation of bile flow; the
surrounding stroma was edematous and peri-
portal foci of necrosis and ductular proliferation
were also observed. With chronic ANIT adminis-
tration these lesions gradually regressed but pro-
liferation of bile duct persists without interference
with bile flow and liver cell injury (Goldfarb et al.,
1962). Our results confirm, after 16 weeks of
ANIT administration, ductular proliferation and
normal hepatocellular structure as the most im-
portant features, present in all treated animals.
Biliary proliferation is explained as a mechanism
of bile duct repair to restore the number of
intrahepatic ducts and duct secretory function.
This indicator of liver disease is well correlated
with the significant lower weight of treated ani-
mals at the time of the experiment. Iron deposits at
portal macrophages and Kupffer cells may be
related to intravascular haemolysis or previous
hepatocellular necrosis.
In order to address if mitochondrial dysfunction
might be one cause of the development of the
pathological features associated with cholestatic
diseases, we analyzed mitochondrial function.
ANIT-induced changes in hepatobiliary morphol-
ogy were accompanied by a significant decrease in
state 3 respiration but no change in state 4
respiration of liver mitochondria isolated from
treated rats, when compared with controls. Since
state 4 respiration is mainly dependent on the
proton leak, changes in ADP-stimulated respira-
tion probably reflect an impairment at the level of
the oxidative phosphorylative system, further sub-
stantiated by the decrease in ATPase activity. The
evidence of a similar membrane potential devel-
oped upon succinate oxidation, in both prepara-
tions, further indicates that the difference in
respiratory rates are the result of specific altera-
tions on the oxidative phosphorylative system and
not at the level of the DpH dissipated through the
subunits of the ATPase. If this was the case, an
increase in state 4 respiration and a decrease in
mitochondrial membrane potential should be
noticed. Interestingly, RCR slightly decreased
(while not statistically significant), although the
great decrease in state 3 respiration. This observa-
tion may result from the fact that state 4 respira-
Fig. 4. Mitochondrial membrane potential measurements with
a TPP-selective electrode. Reactions were carried out in 1 ml
of reaction medium, supplemented with 2 mM rotenone and 1
mg mitochondria. Energization was achieved with 5 mM
succinate. The traces are representative of experiments per-
formed with four different mitochondrial preparations.
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tion also slightly decreased (while not statistically
significant), which may lead to the observed no
alteration in the ratio between state 3 and state 4
(RCR). In contrast, state 3 respiration reflects the
integration of both reactions of ATP ‘turnover’
and those of succinate oxidation. The decrease in
repolarization rate, membrane potential upon
ADP addition and ATPase activity, probably are
the result of an irreversible effect upon chronic
ANIT administration and consequent bile acids
accumulation.
Associated with alterations in oxidative phos-
phorylation, defective mitochondrial capacity in
buffering external calcium and enhanced suscept-
ibility to the calcium-sensitive MPT were ob-
served, in our present study. Several reports have
demonstrated toxic bile acids as potent inducers of
the MPT, pointing the transition as a final
common pathway responsible for ATP depletion
and cytotoxicity of the accumulated compounds
during cholestasis (Botla et al., 1995; Gores et al.,
1998; Rolo et al., 2000, 2003). MPT induction is a
condition often related to mitochondrial and
consequent cell dysfunction, and probably reflects
a direct causative effect on the regulation of the
CyA-sensitive MPT, since such susceptibility to
calcium release is only observed upon chronic
ANIT administration but not on acute cholestasis
(Rolo et al., 2002b). Indeed, the fact that only
MPT-dependent calcium release but not calcium
uptake was affected in the treated group may
suggest an effect at the often indicated as the MPT
pore components. Furthermore, since state 3
respiration was significantly decreased, we may
suggest that such effect may occur at the level of
the adenine nucleotide translocator, explaining not
only the increased susceptibility to the calcium-
dependent MPT as well as the decreased state 3
respiration.
Fig. 5. Calcium accumulation capacity, measured with a TPP-selective electrode. Several calcium pulses were added in order to
induce MPT. Experimental conditions are the same as in Fig. 4. The traces are representative of experiments performed with four
different mitochondrial preparations.
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Both mitochondrial metabolism impairment
and hydrophobic bile acids accumulation are
associated with increased production of oxygen
free radical species and development of oxidative
damage in cholestasis (Sokol et al., 1991; Krahen-
buhl et al., 1995; Baron and Muriel, 1999; Sokol et
al., 1993, 1995; Patel and Gores, 1997; Sokol et al.,
1998; Gumpricht et al., 2000; Vendemiale et al.,
2002). The persistence of reactive oxygen species
formation in cholangiocytes even 4 week after
cessation of ANIT treatment was observed re-
cently by LeSage et al. (2001). So, we are tempted
to suggest that the observed decrease in state 3
respiration and ATPase activity may be a conse-
quence of oxidative damage to the proteins or,
since we are in the presence of a treatment of 16
weeks, the result of DNA damage by oxidative
stress. This correlates well with our study of short-
term chronic cholestasis, in which no reduced
activity of the respiratory chain was observed
(Rolo et al., 2002a). Furthermore, other studies
have shown that the activities of complexes I and
III recover within days after reversal of bile-duct-
ligation (Krahenbuhl et al., 1998). Additionally,
conditions of oxidative stress act as negative
modulators of the MPT. Being oxidative stress a
phenomenon subsequent to bile acids accumula-
tion during ANIT-induced cholestasis, oxidative
damage to cardiolipin, mitochondrial DNA or
proteins, may result in the observed mitochondrial
dysfunction.
So we propose that the initial enhancement of
mitochondrial function as an adaptive response by
the hepatocyte to limit ANIT-induced acute liver
cholestasis (Rolo et al., 2002b), progresses to a
stage characterized by disruption of mitochondrial
calcium homeostasis but yet with a probable
recovery on respiratory chain and biochemical
indices, after ANIT removal (Rolo et al., 2002a).
In a later stage, several cell functions and mechan-
isms are probably affected, as shown by decreased
efficiency of mitochondrial oxidative phosphory-
lation and calcium homeostasis, resulting in gen-
eral hepatocyte dysfunction as shown by the
biochemical parameters, determining the outcome
of the disease. These studies may be important to
better understand the course of cholestasis, since
human cholestatic liver disease progress slowly
over time, and provide further insight into the role
of mitochondrial dysfunction in the process. A
progressive and differential impairment of mito-
chondrial function is observed, depending on the
stage of chemical-induced cholestasis.
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Fig. 6. Typical measurements of extramitochondrial calcium
movements using the fluorescent calcium-sensitive probe Cal-
cium Green 5-N. The reactions were carried out in 2 ml of
reaction medium, supplemented with 2 mM rotenone, 0.6 mg
mitochondria, 0.4 mM oligomycin, 5 mM succinate and 100 nM
Calcium Green 5-N. Fluorescence was monitored continuously
for 50 s, prior to the addition of calcium (CaCl2) to a final
concentration of 15 mM. Fluorescence was monitored continu-
ously for an additional 4 min, and stopped with excess EGTA
to obtain the baseline. Where indicated (first arrow), CyA (0.4
mM) was added prior to calcium. Calcium fluxes are expressed
as RFUs. The traces are representative of experiments per-
formed with four different mitochondrial preparations.
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